Top ten of 2021 #4 – Growing older and more stigmatised on methadone

In a compelling study from Dublin, Paula Mayock and Shane Butler (Trinity College) make the point that little is known about the stigma experienced by individuals attending drug treatment services over prolonged periods.  They explored this through the lived-experience narratives of 25 people prescribed long-term methadone. Their findings ‘reveal the intersection of stigma with age … Continue reading Top ten of 2021 #4 – Growing older and more stigmatised on methadone

Top ten of 2021 #5 – Choice in addiction treatment

As a GP in inner-city Glasgow in the 1990s, I looked after patients with heroin addiction. I got to know many of them well, I knew their families, I immunised their children and, distressingly, I saw some of them die. Because of the nature of general practice, I saw the dreadful impact of those deaths … Continue reading Top ten of 2021 #5 – Choice in addiction treatment

Did a recovery strategy cause drug deaths?

There’s a narrative that’s been around for a while, but it’s been gaining ground in the last few months. This last couple of months alone, it’s been in the ether, permeating social media conversations and even appeared in an academic paper. The issue relates to recovery-oriented drug policies and the tone is negative.  The thrust … Continue reading Did a recovery strategy cause drug deaths?

Growing older and more stigmatised on methadone

In a compelling study from Dublin, Paula Mayock and Shane Butler (Trinity College) make the point that little is known about the stigma experienced by individuals attending drug treatment services over prolonged periods.  They explored this through the lived-experience narratives of 25 people prescribed long-term methadone. Their findings ‘reveal the intersection of stigma with age … Continue reading Growing older and more stigmatised on methadone

Optimism? Or, is it low expectations?

The feds recently published an article touting the long-term success of buprenorphine: In the first long-term follow-up of patients treated with buprenorphine/naloxone (Bp/Nx) for addiction to opioid pain relievers, half reported that they were abstinent from the drugs 18 months after starting the therapy. After 3.5 years, the portion who reported being abstinent had risen … Continue reading Optimism? Or, is it low expectations?

Don’t believe the hype

About that Huffington Post article covering Obama's addiction speech a few weeks ago. ALLEGATION FACT FACT A Huffington Post investigation published in January found that the treatment industry overwhelmingly resists a medication-assisted model based on decades-old beliefs about sobriety that have been passed down by those in recovery, but have never been rigorously tested. Suboxone is the number 39 … Continue reading Don’t believe the hype